Keyphrases
Cancer Development
33%
Cancer Immunotherapy
100%
Cancer Treatment
33%
Cancer Vaccine
33%
Checkpoint Inhibitors
33%
Chimeric Antigen Receptor T Cells (CAR-T)
33%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
33%
Human Immune System
33%
Immune Checkpoint Inhibitors
33%
Immune Signaling
33%
Immunotherapeutic Strategy
33%
Immunotherapeutics
33%
In Cancer
100%
Non-responders
33%
Oncolytic Virus
33%
Programmed Death-ligand 1 (PD-L1)
33%
Real Possibility
33%
Solid Tumor Therapy
33%
Tumor Immunity
33%
Tumor Subtype
33%
Immunology and Microbiology
Cancer Immunotherapy
100%
Chimeric Antigen Receptor T-Cell
20%
Cytotoxic T Cell
20%
Immune System
20%
Immunity
40%
Immunomodulating Drugs
20%
Immunotherapy
100%
Oncolytic Virus
20%
Programmed Death 1 Receptor
20%
Tumor Immunity
20%
Tumor Vaccine
20%
Medicine and Dentistry
Cancer Therapy
20%
Chimeric Antigen Receptor T-Cell
20%
Cytotoxic T-Cell
20%
Hope
20%
Immune Checkpoint Inhibitor
20%
Immune System
20%
Immunity
20%
Immunomodulating Agent
20%
Immunotherapy
100%
Malignant Neoplasm
20%
Neoplasm
20%
Oncolytic Virus
20%
Programmed Death 1 Receptor
20%
Solid Malignant Neoplasm
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
16%
Immune Checkpoint Inhibitor
16%
Immunomodulating Agent
16%
Immunotherapy
100%
Malignant Neoplasm
100%
Neoplasm
33%
Oncolytic Virus
16%
Programmed Death 1 Receptor
16%
Solid Malignant Neoplasm
16%
Tumor Vaccine
16%